Business
Brokers name 3 ASX shares to buy right now 3 December 2020
Australia’s top brokers have been busy adjusting their estimates and recommendations again, leading to the release of a large number of broker notes this week.
Three broker buy ratings that have caught my eye are summarised below. Here’s why brokers think these ASX shares are in the buy zone:
According to a note out of UBS, its analysts have retained their buy rating and $346.00 price target on this biotherapeutics giant’s shares. The broker has been looking at its plasma collection openings and is confident CSL will achieve its target of 20 to 30 new centres in FY 2021. It expects this to offset a portion of the decline it is facing with collections from COVID-19. And while these COVID headwinds are not easing, the broker…
-
Noosa News20 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test
-
General19 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call
-
Noosa News22 hours agoPeter Dutton insists there’s enough water for his seven nuclear plants, contradicting shadow frontbencher
-
General21 hours agoCanberra man named as doctor accused of rape after suppression order lifted